Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Atrion Corporation Increases Quarterly Cash Dividend by 17%

August 3, 2010 1:45 pm | by The Associated Press | News | Comments

Atrion Corporation (NASDAQ: ATRI) today announced an increase in its quarterly cash dividend from 36 cents per share to 42 cents per share. Specifically, the Board of Directors declared a quarterly dividend of 42 cents per share on its outstanding shares of Common Stock. This dividend...

Steris reports fiscal 1Q loss on rebate charge

August 3, 2010 12:45 pm | by The Associated Press | News | Comments

Medical products maker Steris Corp. said Tuesday it lost $45.2 million in its fiscal first quarter due to an accounting charge for a rebate program, but its adjusted results beat Wall Street expectations.The Mentor, Ohio, said it lost 76 cents per share in the three months that ended June 30....

AGA Medical reports 2Q profit as sales edge higher

August 3, 2010 10:45 am | by The Associated Press | News | Comments

Heart device maker AGA Medical Holdings Inc. said Tuesday it turned a profit in the second quarter compared to a year ago, when it took a loss after paying out millions in dividends.AGA reported net income of $3.6 million, or 7 cents per share. A year ago AGA took a loss of $2.1 million, or 10...

Advertisement

ArQule lung cancer treatment one step closer to market

August 3, 2010 10:40 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Woburn-based biotech ArQule Inc. and New Jersey pharmaceutical firm Daiichi Sankyo Co. Ltd. are heading toward a Phase 3 clinical trial of their treatment for non-small cell lung cancer, and Daiichi Sankyo is filing a Special Protocol Assessment with the FDA to guide the design of the trial.

TOPICS:

Chili peppers come with blood pressure benefits

August 3, 2010 10:40 am | by EurekAlert | News | Comments

(Cell Press) For those with high blood pressure, chili peppers might be just what the doctor ordered, according to a study reported in the August issue of Cell Metabolism, a Cell Press publication. While the active ingredient that gives the peppers their heat -- a compound known as...

TOPICS:

PMA Final Decisions for June 2010

August 3, 2010 10:39 am | by U.S. Food & Drug Administration | News | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions for June 2010.

TOPICS:

Boston Scientific begins adding patients in stent trial

August 3, 2010 10:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Natick medical device giant Boston Scientific Corp. has begun enrolling patients in its EVOLVE clinical trial to test the safety of its Synergy coronary stent. The trial is expected to enroll 291 patients in 35 locations throughout Europe, Australia and New Zealand.

Curis begins trial of cancer treatment

August 3, 2010 10:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Curis Inc. has treated its first patient in a Phase 1b expansion trial for its small molecule drug candidate, CUDC-101, intended to treat advanced head and neck, gastric, breast and liver cancers.

Advertisement

InQ Biosciences Appoints John Ryder as Senior Vice President, Sales & Marketing

August 3, 2010 10:37 am | by Bio-Medicine.Org | News | Comments

HUNTSVILLE, Ala. and MARLBOROUGH, Mass. , Aug. 3 /- InQ Biosciences Corporation , a provider of innovative technologies for cell growth and research, announced the appointment of John Ryder as Senior Vice President, Sales and Marketing. Ryder will be based in InQ's sales office in...

TOPICS:

Fujifilm Dimatix achieves a strong showing at Shanghai 2010 Ad, print and sign expo

August 3, 2010 8:37 am | by I-Micronews | News | Comments

Fujifilm Dimatix products featured in 36 OEM printers ? 28 of which use new Spectra® Polaris Q-Class printheads. Asian launch of Fujifilm Dimatix DMP-3000 Material Printer and new D-Class printheads for materials deposition applications was enthusiastically received.

Acorda 2Q loss narrows on Ampyra sales

August 3, 2010 7:45 am | by The Associated Press | News | Comments

Biotechnology company Acorda Therapeutics Inc. said Tuesday its second-quarter loss narrowed on a boost in sales of the multiple sclerosis drug Ampyra.The company lost $6.8 million, or 18 cents per share, compared with a loss of $23.3 million, or 62 cents per share, during the same period a...

Mednax 2Q earnings climb 14 pct to $49.4 million

August 3, 2010 7:45 am | by The Associated Press | News | Comments

National physician group Mednax Inc. said Tuesday its second-quarter earnings climbed 14 percent, as contributions from newly acquired doctor practices helped boost revenue.Mednax earned $49.4 million, or $1.04 per share, in the three months that ended June 30. That compares to earnings of...

Tenet turns 2Q profit on greater revenue per visit

August 3, 2010 7:45 am | by The Associated Press | News | Comments

Hospital operator Tenet Healthcare Corp. on Tuesday reported a profit in the second quarter as it received more revenue per patient visit.Tenet posted net income of $25 million, or 5 cents per share. That compares with a loss of $15 million, or 3 cents per share, one year ago. Revenue rose 3...

Sun Healthcare Group offering 19.3 million shares

August 3, 2010 7:45 am | by The Associated Press | News | Comments

Health care facility operator Sun Healthcare Group Inc. said Tuesday it is publicly offering 19.3 million shares of common stock.The company will also give underwriters a 30-day option to buy up to 2.9 million additional shares of stock to cover any overallotments. Sun said it would use the...

PerkinElmer acquires imaging tech firm VisEn Medical

August 3, 2010 7:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

PerkinElmer Inc., a Waltham provider of equipment and services to support human and environment health, has bought Bedford molecular imaging technology company VisEn Medical Inc.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading